Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 5952890, 8 pages
http://dx.doi.org/10.1155/2016/5952890
Research Article

Evaluation of Influenza Vaccination Efficacy: A Universal Epidemic Model

Vector State Research Center of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia

Received 31 May 2016; Revised 4 August 2016; Accepted 18 August 2016

Academic Editor: Puja Myles

Copyright © 2016 Lily Ph. Nizolenko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Zhang, L. Wang, R. W. Compans, and B.-Z. Wang, “Universal influenza vaccines, a dream to be realized soon,” Viruses, vol. 6, no. 5, pp. 1974–1991, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. R. D. De Vries, A. F. Altenburg, and G. F. Rimmelzwaan, “Universal influenza vaccines, science fiction or soon reality?” Expert Review of Vaccines, vol. 14, no. 10, pp. 1299–1301, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Fiers, M. De Filette, A. Birkett, S. Neirynck, and W. Min Jou, “A ‘universal’ human influenza A vaccine,” Virus Research, vol. 103, no. 1-2, pp. 173–176, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. M. De Filette, W. Fiers, W. Martens et al., “Improved design and intranasal delivery of an M2e-based human influenza A vaccine,” Vaccine, vol. 24, no. 44–46, pp. 6597–6601, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Pica and P. Palese, “Toward a universal influenza virus vaccine: prospects and challenges,” Annual Review of Medicine, vol. 64, pp. 189–202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. P. C. Soema, E. Van Riet, G. Kersten, and J.-P. Amorij, “Development of cross-protective influenza A vaccines based on cellular responses,” Frontiers in Immunology, vol. 6, article 237, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Y. Lee, J. H. Y. Tai, S. M. McGlone et al., “The potential economic value of a 'universal' (multi-year) influenza vaccine,” Influenza and other Respiratory Viruses, vol. 6, no. 3, pp. 167–175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. G. Bachinsky and L. P. Nizolenko, “A universal model for predicting dynamics of the epidemics caused by special pathogens,” BioMed Research International, vol. 2013, Article ID 467078, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. R. L. Haupt and S. E. Haupt, Practical Genetic Algorithms, John Wiley & Sons, New York, NY, USA, 2nd edition, 2004.
  10. A. G. Bachinsky and L. P. Nizolenko, “A universal model of epidemic: optimizing interventions,” Universal Journal of Public Health, vol. 2, no. 4, pp. 111–117, 2014. View at Google Scholar
  11. I. M. Longini Jr., M. E. Halloran, A. Nizam, and Y. Yang, “Containing pandemic influenza with antiviral agents,” American Journal of Epidemiology, vol. 159, no. 7, pp. 623–633, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. R. R. Regoes and S. Bonhoeffer, “Emergence of drug-resistant influenza virus: population dynamical considerations,” Science, vol. 312, no. 5772, pp. 389–391, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. C. L. Addy, I. M. Longini Jr., and M. Haber, “A generalized stochastic model for the analysis of infectious disease final size data,” Biometrics, vol. 47, no. 3, pp. 961–974, 1991. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Fraser, “Estimating individual and household reproduction numbers in an emerging epidemic,” PLoS ONE, vol. 2, no. 8, article e758, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Fraser, D. A. T. Cummings, D. Klinkenberg, D. S. Burke, and N. M. Ferguson, “Influenza transmission in households during the 1918 pandemic,” American Journal of Epidemiology, vol. 174, no. 5, pp. 505–514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Viboud, T. Tam, D. Fleming, A. Handel, M. A. Miller, and L. Simonsen, “Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic,” Vaccine, vol. 24, no. 44–46, pp. 6701–6707, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Diekmann, J. A. Heesterbeek, and J. A. Metz, “On the definition and the computation of the basic reproduction ratio Ro in models for infectious diseases in heterogeneous populations,” Journal of Mathematical Biology, vol. 28, no. 4, pp. 365–382, 1990. View at Publisher · View at Google Scholar · View at MathSciNet
  18. J. A. P. Heesterbeek, “A brief history of R0 and a recipe for its calculation,” Acta Biotheoretica, vol. 50, no. 3, pp. 189–204, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Carrat, J. Luong, H. Lao, A.-V. Sallé, C. Lajaunie, and H. Wackernagel, “A ‘small-world-like’ model for comparing interventions aimed at preventing and controlling influenza pandemics,” BMC Medicine, vol. 4, article 26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Y. Lee, S. T. Brown, P. Cooley et al., “Vaccination deep into a pandemic wave: potential mechanisms for a ‘third wave’ and the impact of vaccination,” American Journal of Preventive Medicine, vol. 39, no. 5, pp. e21–e29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Liu and S. Xia, “Toward effective vaccine deployment: a systematic study,” Journal of Medical Systems, vol. 35, no. 5, pp. 1153–1164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Plans-Rubió, “The vaccination coverage required to establish herd immunity against influenza viruses,” Preventive Medicine, vol. 55, no. 1, pp. 72–77, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. O. Sharomi, C. N. Podder, A. B. Gumel, S. Mahmud, and E. Rubinstein, “Modelling the transmission dynamics and control of the novel 2009 swine influenza (H1N1) pandemic,” Bulletin of Mathematical Biology, vol. 73, no. 3, pp. 515–548, 2011. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  24. G. Milne, J. Kelso, and H. Kelly, “Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines,” Journal of the Royal Society Interface, vol. 7, no. 45, pp. 573–586, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. D. M. Skowronski, N. Z. Janjua, G. De Serres et al., “Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009,” British Medical Journal, vol. 342, Article ID c7297, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Valenciano, E. Kissling, J.-M. Cohen et al., “Estimates of pandemic influenza vaccine effectiveness in europe, 2009-2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) Multicentre Case-Control Study,” PLoS Medicine, vol. 8, no. 1, Article ID e1000388, 12 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Wallinga and M. Lipsitch, “How generation intervals shape the relationship between growth rates and reproductive numbers,” Proceedings of the Royal Society B: Biological Sciences, vol. 274, no. 1609, pp. 599–604, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Chowell, M. A. Miller, and C. Viboud, “Seasonal influenza in the United States, France, and Australia: transmission and prospects for control,” Epidemiology and Infection, vol. 136, no. 6, pp. 852–864, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. N. M. Ferguson, D. A. T. Cummings, C. Fraser, J. C. Cajka, P. C. Cooley, and D. S. Burke, “Strategies for mitigating an influenza pandemic,” Nature, vol. 442, no. 7101, pp. 448–452, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. D. M. Bell, A. Nicoll, K. Fukuda et al., “Nonpharmaceutical interventions for pandemic influenza, international measures,” Emerging Infectious Diseases, vol. 12, no. 1, pp. 81–87, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. R. Tuite, A. L. Greer, M. Whelan et al., “Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza,” Canadian Medical Association Journal, vol. 182, no. 2, pp. 131–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Carrat, E. Vergu, N. M. Ferguson et al., “Time lines of infection and disease in human influenza: a review of volunteer challenge studies,” American Journal of Epidemiology, vol. 167, no. 7, pp. 775–785, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Hirotsu, H. Ikematsu, N. Iwaki et al., “Effects of antiviral drugs on viral detection in influenza patients and on the sequential infection to their family members—serial examination by rapid diagnosis (Capilia) and virus culture,” International Congress Series, vol. 1263, pp. 105–108, 2004. View at Publisher · View at Google Scholar
  34. S. P. Kuster, P. S. Shah, B. L. Coleman et al., “Incidence of influenza in healthy adults and healthcare workers: A systematic review and meta-analysis,” PLoS ONE, vol. 6, no. 10, Article ID e26239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S. C. Wood, A. Alexseiv, and V. H. Nguyen, “Effectiveness and economical impact of vaccination against influenza among a working population in Moscow,” Vaccine, vol. 17, no. 3, pp. S81–S87, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Fine, K. Eames, and D. L. Heymann, “‘Herd immunity’: a rough guide,” Clinical Infectious Diseases, vol. 52, no. 7, pp. 911–916, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. “Influenza Surveillance System in Russia: Epidemic situation,” Research Institute of Influenza, 2016, http://www.influenza.spb.ru/en/influenza_surveillance_system_in_russia/epidemic_situation.
  38. “Resolution of the Chief Medical Officer of St. Petersburg,” Rospotrebnadzor, 2016 (Russian), http://78.rospotrebnadzor.ru/c/document_library/get_file?uuid=4c2e5fd8-71ec-4122-a2a9-94aaa2939d59&groupId=935484.
  39. K. F. Cheng and P. C. Leung, “What happened in China during the 1918 influenza pandemic?” International Journal of Infectious Diseases, vol. 11, no. 4, pp. 360–364, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Chowell, C. E. Ammon, N. W. Hengartner, and J. M. Hyman, “Transmission dynamics of the great influenza pandemic of 1918 in Geneva, Switzerland: assessing the effects of hypothetical interventions,” Journal of Theoretical Biology, vol. 241, no. 2, pp. 193–204, 2006. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus